Abstract
Inflammatory fibroid polyp (IFP) is a benign reactive uncommon submucosal lesion of the gastrointestinal tract, the small intestine being the most common site of origin. Histologically, IFPs are characterized by spindle cells, a heavy inflammatory infiltrate including eosinophils and onion-sheet-like formation of lesional cells around blood vessels. We present a case report of an IFP harboring an activation mutation in the PDGFRα gene. The lesion was positive for CD34, PDGFRα, and p-PDGFRα immunostaining but was negative for c-KIT and desmin. After a sequencing analysis of KIT and PDGFRα, a mutation consisting of an in-frame deletion of codons 567-571 and a missense mutation in codon 566 (S566R) of PDGFRα was observed. This mutation could activate key cellular pathways with involvement in the pathogenesis of this entity. We concluded that more studies are necessary in order to clarify if this finding is a biologically distinct behavior or, on the contrary, represents a specific feature of the IFP.
This is a preview of subscription content, log in via an institution to check access.
References
Arber DA, Kamel OW, Van de Rijn M et al (1995) Frequent presence of the Epstein–Barr virus in inflammatory pseudotumor. Hum Pathol 26:1093–1098
Wysocki AP, Taylor G, Windsor JA (2007) Inflammatory fibroid polyps of the duodenum: a review of the literature. Dig Surg 24:162–168
Daum O, Hes O, Vanecek T et al (2003) Vanek’s tumor (inflammatory fibroid polyp). Report of 18 cases and comparison with three cases of original Vanek’s series. Ann Diagn Pathol 7:337–347
Ozolek JA, Sasatomi E, Swalsky PA et al (2004) Inflammatory fibroid polyps of the gastrointestinal tract: clinical, pathologic, and molecular characteristics. Appl Immunohistochem Mol Morphol 12:59–66
Kirsch R, Gao ZH, Riddell R (2007) Gastrointestinal stromal tumors: diagnostic challenges and practical approach to differential diagnosis. Adv Anat Pathol 14:261–285
Makhlouf HR, Sobin LH (2002) Inflammatory myofibroblastic tumors (inflammatory pseudotumors) of the gastrointestinal tract: how closely are they related to inflammatory fibroid polyps? Hum Pathol 33:307–315
Schildhaus HU, Cavlar T, Binot E et al (2008) Inflammatory fibroid polyps harbour mutations in the platelet-derived growth factor receptor alpha (PDGFRA) gene. J Pathol 216:176–182
Miettinen M, Lasota J (2001) Gastrointestinal stromal tumors—definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 438:1–12
Corless CL, McGreevey L, Haley A et al (2002) KIT mutations are common in incidental gastrointestinal stromal tumors one centimeter or less in size. Am J Pathol 160:1567–1572
Heinrich MC, Corless CL, Demetri GD et al (2003) Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor. J Clin Oncol 21:4342–4349
Carney JA, Stratakis CA (2008) Stromal, fibrous, and fatty gastrointestinal tumors in a patient with a PDGFRA gene mutation. Am J Surg Pathol 32:1412–1420
Rossi G, Valli R, Bertolini F et al (2005) PDGFR expression in differential diagnosis between KIT-negative gastrointestinal stromal tumours and other primary soft-tissue tumours of the gastrointestinal tract. Histopathology 46:522–531
Santos Gda C, Alves VA, Wakamatsu A et al (2004) Inflammatory fibroid polyp: an immunohistochemical study. Arq Gastroenterol 41:104–107
Spritz RA, Strunk KM, Lee ST et al (1994) A YAC contig spanning a cluster of human type III receptor protein tyrosine kinase genes (PDGFRA-KIT-KDR) in chromosome segment 4q12. Genomics 22:431–436
Lopez-Guerrero JA, Navarro S, Noguera R et al (2005) Mutational analysis of the c-KIT AND PDGFRalpha in a series of molecularly well-characterized synovial sarcomas. Diagn Mol Pathol 14:134–139
Hoei-Hansen CE, Kraggerud SM, Abelar VM, Kaern J et al (2007) Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers. Mol Cancer 6:12
Do I, Santini Araujo E, Kalil RK, Bacchini P et al (2007) Protein expression of KIT and ene mutation of c-KIT and PDGFRs in Ewing sarcomas. Pathology 203:127–134
Antonescu CR, Busam KJ, Francone TD et al (2007) L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition. Int J Cancer 121:257–264
Swick BL, Ravdel L, Fitzpatrick JE et al (2008) Platelet-derived growth factor receptor alpha mutational status and immunohistochemical expression in Merkel cell carcinoma: implications for treatment with imatinib mesylate. J Cutan Pathol 35:197–202
Metzgeroth G, Walz C, Score J et al (2007) Recurrent finding of the FIP1L1-PDGFRA fusion gene in eosinophilia-associated acute myeloid leukemia and lymphoblastic T-cell lymphoma. Leukemia 21:1183–1188
Biermann K, Goke F, Nettersheim D et al (2007) c-KIT is frequently mutated in bilateral germ cell tumours and down-regulated during progression from intratubular germ cell neoplasia to seminoma. J Pathol 213(3):311–318
Lasota J, Miettinen M (2006) KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs). Semin Diagn Pathol 23:91–102
Shor AC, Agresta SV, D’Amato GZ et al (2008) Therapeutic potential of directed tyrosine kinase inhibitor therapy in sarcomas. Cancer Control 15:47–54
Acknowledgments
The technical assistance of Estela Pons, Elisa Alonso, and Laura Martinez is gratefully acknowledged. This study was supported by grant PI04/0822 from the Instituto Carlos III, Madrid. Spain.
Conflict of interest statement
We declare that we have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calabuig-Fariñas, S., López-Guerrero, J.A., Ribera, M.J.N. et al. Inflammatory fibroid polyp of the small bowel with a mutation in exon 12 of PDGFRα . Virchows Arch 454, 327–331 (2009). https://doi.org/10.1007/s00428-008-0715-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-008-0715-5